Induction of glomerular microclot formation by fibrin monomer infusion.
D000085:Acetates; D000311:Adrenal Glands / Q000473:pathology; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001779:Blood Coagulation Factors / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D002196:Capillaries / Q000187:drug effects; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D005260:Female; D005337:Fibrin / Q000494:pharmacology*; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D007678:Kidney Glomerulus / Q000098:blood supply / Q000187:drug effects* / Q000473:pathology; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008297:Male; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000209:etiology; D013154:Spleen / Q000473:pathology
D000085:Acetates; D000614:Aminocaproates; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D007611:Aprotinin